Skip to content

Prevalence of Pre-menstrual syndrome (PMS) and its efficacy using Ashwagandha Vati.

The Observational study of the Prevalence of Pre-menstrual syndrome (PMS) in college going students & study the Clinical efficacy of Ashwagandha Vati in PMS. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081581
Enrollment
335
Registered
2025-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

None listed

Sponsors

Dr Abhishek Walunj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject fulfilling diagnostic criteria of Pre-menstrual syndrome. Regular menstruating females. Subject irrespective of marital status, obstetric status, education and occupation.

Exclusion criteria

Exclusion criteria: Subject taking psychiatric treatment. Women with known history of severe systemic illnesses. Women who are taking Hormonal treatment for menstrual regulation, Polycystic ovarian disease & acne.

Design outcomes

Primary

MeasureTime frame
Improvement of PMS reduction in score i.e less than 132Timepoint: Baseline, 1st day of menses for Three months i.e 1st day of First month, 1st day of Second month and 1st day of Third month

Secondary

MeasureTime frame
Observational study of PMS and side effect of drug. Relation with prakruti and pmsTimepoint: baseline 1st day of each menstrual cycle till 3 months

Countries

India

Contacts

Public ContactDr Swati S Mohite

Bharti Vidyapeeth Deemed to be University

swati.mohite@bharatividyapeeth.edu9822004562

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026